Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bulky Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT00823186
What this trial is testing

Dose-finding Study of Weekly Paclitaxel and Cisplatin in FIGO IB2 and Bulky IIA Cervical Cancer

Who this might be right for
Cervical Cancer
Chang Gung Memorial Hospital 21
Large-scale testing (Phase 3)Study completedNCT01313689
What this trial is testing

Ofatumumab vs Physician's Choice in Subjects With Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia

Who this might be right for
Leukaemia
Novartis Pharmaceuticals 122
Early research (Phase 1)Study completedNCT00028405
What this trial is testing

Photodynamic Therapy System for Patients With Refractory/Unresponsive Solid Tumors

Who this might be right for
Liver MetastasisPelvic CancerHead and Neck Cancer+5 more
Light Sciences LLC 48
Not applicableEnded earlyNCT04779489
What this trial is testing

Checkpoint Inhibitor and Radiation Therapy in Bulky, Node-Positive Bladder Cancer

Who this might be right for
Bladder Cancer
University of Texas Southwestern Medical Center 1
Testing effectiveness (Phase 2)Study completedNCT00070018
What this trial is testing

S0313 Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, and Radiation Therapy Followed By Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Stage I or Stage II Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
SWOG Cancer Research Network 46
Not applicableStudy completedNCT00850200
What this trial is testing

Proton Therapy for Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
University of Florida 20
Testing effectiveness (Phase 2)Ended earlyNCT01390584
What this trial is testing

Chemotherapy Based on PET Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma

Who this might be right for
Lymphoma
ECOG-ACRIN Cancer Research Group 6
Not applicableStudy completedNCT01578967
What this trial is testing

Induction Chemo w/ABVD Followed by Brentuximab Vedotin Consolidation in Newly Diagnosed, Non-Bulky Stage I/II Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma, Adult
UNC Lineberger Comprehensive Cancer Center 41
Early research (Phase 1)Study completedNCT00271050
What this trial is testing

External Beam Radiotherapy and Zevalin for Management of Indolent B-Cell Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma, B-Cell
The Cleveland Clinic 12
Post-approval studies (Phase 4)UnknownNCT02752815
What this trial is testing

Reduced Chemotherapy in Low Risk DLBCL

Who this might be right for
Diffuse Large B-cell Lymphoma
Ruijin Hospital 290
Not applicableUnknownNCT01399931
What this trial is testing

Dual Point PET Scan in Early Stage Hodgkin Lymphoma Patients With Bulky Lesions

Who this might be right for
Hodgkin's Lymphoma
Ospedale Santa Croce-Carle Cuneo 150
Not applicableUnknownNCT01680523
What this trial is testing

Radical Hysterectomy Followed by Tailored Adjuvant Therapy Versus Primary Chemoradiation Therapy in Bulky Early-stage Cervical Cancer (KGOG 1029)

Who this might be right for
Cervical Cancer
Asan Medical Center 409
Large-scale testing (Phase 3)Study completedNCT01478542
What this trial is testing

OPTIMAL>60 / DR. CHOP, Improvement of Therapy of Elderly Patients with CD20+ DLBCL Using Rituximab Optimized and Liposomal Vincristine

Who this might be right for
CD20+ Aggressive B-Cell Lymphoma
Universität des Saarlandes 1,152
Testing effectiveness (Phase 2)Ended earlyNCT01708161
What this trial is testing

A Phase Ib/II Study of the Combination of BYL719 Plus AMG 479 in Adult Patients With Selected Solid Tumors

Who this might be right for
PIK3CA Mutated Advanced Solid TumorsPIK3CA Amplified Advanced Solid Tumors
Novartis Pharmaceuticals 47
Not applicableUnknownNCT02969278
What this trial is testing

Groin Sentinel Node Biopsy and 18FDG-PET/CT in cN0 Vulvar Cancer Patients Candidate to Standard Lymphadenectomy

Who this might be right for
Vulvar Cancer
Catholic University of the Sacred Heart 50
Testing effectiveness (Phase 2)Looking for participantsNCT06377566
What this trial is testing

BV-AVD in People With Bulky Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
Memorial Sloan Kettering Cancer Center 71
Testing effectiveness (Phase 2)Study completedNCT00496873
What this trial is testing

Evaluation of the Safety and Efficacy of Nipent, Cytoxan, and Rituxan

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 100
Large-scale testing (Phase 3)Study completedNCT00112931
What this trial is testing

Rituximab in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Follicular Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
University College, London 462
Testing effectiveness (Phase 2)Study completedNCT02871219
What this trial is testing

Obinutuzumab and Lenalidomide in Treating Patients With Previously Untreated Stage II-IV Grade 1-3a Follicular Lymphoma

Who this might be right for
Ann Arbor Stage II Grade 1 Follicular LymphomaAnn Arbor Stage II Grade 2 Follicular LymphomaAnn Arbor Stage III Grade 1 Follicular Lymphoma+10 more
M.D. Anderson Cancer Center 96
Testing effectiveness (Phase 2)Study completedNCT00184093
What this trial is testing

Study of Gemcitabine and Concurrent Radiation Followed by Adjuvant Hysterectomy in Bulky Stage Ib and IIa Cervical Carcinoma

Who this might be right for
Uterine Cervical Cancer
University of Southern California 35
Next Page